Topical therapies for osteoarthritis

Area of Science:

• Pharmacology and Therapeutics
• Pain Management
• Rheumatology

Background:

• Osteoarthritis (OA) pain management often involves oral analgesics like paracetamol and NSAIDs.
• Oral NSAIDs provide efficacy but carry risks of gastrointestinal, cardiovascular, renal, and hepatic adverse events.
• Minimizing systemic exposure to NSAIDs is crucial for patient safety in OA treatment.

Purpose of the Study:

• To review the pharmacology, efficacy, safety, and tolerability of topical NSAIDs, salicylates, and capsaicin for OA pain.
• To compare the benefits and risks of topical therapies versus oral analgesics for osteoarthritis.
• To inform clinical practice regarding the use of topical agents in OA pain management.

Main Methods:

• Comprehensive literature review of pharmacological properties, clinical trials, and safety data.
• Analysis of evidence supporting the efficacy and tolerability of topical NSAIDs, salicylates, and capsaicin.
• Evaluation of treatment guidelines from major orthopedic and rheumatology organizations.

Main Results:

• Topical NSAIDs demonstrate substantial evidence of efficacy and safety, comparable to oral NSAIDs with reduced systemic exposure.
• Topical NSAIDs are recommended by major guidelines for mild to moderate OA, especially for localized joint pain.
• Topical salicylates and capsaicin show less robust efficacy and carry potential safety concerns.

Conclusions:

• Topical NSAIDs are a valuable therapeutic option for OA pain, offering localized relief with improved safety profiles.
• Consideration of topical NSAIDs before oral therapies is supported by evidence and clinical guidelines for specific OA patient populations.
• Further research may be needed to fully elucidate the long-term safety and efficacy of capsaicin and salicylates.